The plastic health map: A systematic evidence map of human health studies on plastic-associated chemicals.

Exposure Health Human Plastic Plastic chemicals Systematic evidence map

Journal

Environment international
ISSN: 1873-6750
Titre abrégé: Environ Int
Pays: Netherlands
ID NLM: 7807270

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 23 11 2022
revised: 15 09 2023
accepted: 19 09 2023
medline: 20 11 2023
pubmed: 11 11 2023
entrez: 10 11 2023
Statut: ppublish

Résumé

The global production and use of plastic materials has increased dramatically since the 1960s and there is increasing evidence of human health impacts related to exposure to plastic-associated chemicals. There is, however, no comprehensive, regulatory, post-market monitoring for human health effects of plastic-associated chemicals or particles and it is unclear how many of these have been investigated for effects in humans, and therefore what the knowledge gaps are. To create a systematic evidence map of peer-reviewed human studies investigating the potential effects of exposure to plastic-associated particles/chemicals on health to identify research gaps and provide recommendations for future research and regulation policy. Medline and Embase databases were used to identify peer-reviewed primary human studies published in English from Jan 1960 - Jan 2022 that investigated relationships between exposures to included plastic-associated particles/chemicals measured and detected in bio-samples and human health outcomes. Plastic-associated particles/chemicals included are: micro and nanoplastics, due to their widespread occurrence and potential for human exposure; polymers, the main building blocks of plastic; plasticizers and flame retardants, the two most common types of plastic additives with the highest concentration ranges in plastic materials; and bisphenols and per- or polyfluoroalkyl substances, two chemical classes of known health concern that are common in plastics. We extracted metadata on the population and study characteristics (country, intergenerational, sex, age, general/special exposure risk status, study design), exposure (plastic-associated particle/chemical, multiple exposures), and health outcome measures (biochemical, physiological, and/or clinical), from which we produced the interactive database 'Plastic Health Map' and a narrative summary. We identified 100,949 unique articles, of which 3,587 met our inclusion criteria and were used to create a systematic evidence map. The Plastic Health Map with extracted metadata from included studies are freely available at https://osf.io/fhw7d/ and summary tables, plots and overall observations are included in this report. We present the first evidence map compiling human health research on a wide range of plastic-associated chemicals from several different chemical classes, in order to provide stakeholders, including researchers, regulators, and concerned individuals, with an efficient way to access published literature on the matter and determine knowledge gaps. We also provide examples of data clusters to facilitate systematic reviews and research gaps to help direct future research efforts. Extensive gaps are identified in the breadth of populations, exposures and outcomes addressed in studies of potential human health effects of plastic-associated chemicals. No studies of the human health effects of micro and/or nanoplastics were found, and no studies were found for 26/1,202 additives included in our search that are of known hazard concern and confirmed to be in active production. Few studies have addressed recent "substitution" chemicals for restricted additives such as organophosphate flame retardants, phthalate substitutes, and bisphenol analogues. We call for a paradigm shift in chemical regulation whereby new plastic chemicals are rigorously tested for safety before being introduced in consumer products, with ongoing post-introduction biomonitoring of their levels in humans and health effects throughout individuals' life span, including in old age and across generations.

Sections du résumé

BACKGROUND BACKGROUND
The global production and use of plastic materials has increased dramatically since the 1960s and there is increasing evidence of human health impacts related to exposure to plastic-associated chemicals. There is, however, no comprehensive, regulatory, post-market monitoring for human health effects of plastic-associated chemicals or particles and it is unclear how many of these have been investigated for effects in humans, and therefore what the knowledge gaps are.
OBJECTIVE OBJECTIVE
To create a systematic evidence map of peer-reviewed human studies investigating the potential effects of exposure to plastic-associated particles/chemicals on health to identify research gaps and provide recommendations for future research and regulation policy.
METHODS METHODS
Medline and Embase databases were used to identify peer-reviewed primary human studies published in English from Jan 1960 - Jan 2022 that investigated relationships between exposures to included plastic-associated particles/chemicals measured and detected in bio-samples and human health outcomes. Plastic-associated particles/chemicals included are: micro and nanoplastics, due to their widespread occurrence and potential for human exposure; polymers, the main building blocks of plastic; plasticizers and flame retardants, the two most common types of plastic additives with the highest concentration ranges in plastic materials; and bisphenols and per- or polyfluoroalkyl substances, two chemical classes of known health concern that are common in plastics. We extracted metadata on the population and study characteristics (country, intergenerational, sex, age, general/special exposure risk status, study design), exposure (plastic-associated particle/chemical, multiple exposures), and health outcome measures (biochemical, physiological, and/or clinical), from which we produced the interactive database 'Plastic Health Map' and a narrative summary.
RESULTS RESULTS
We identified 100,949 unique articles, of which 3,587 met our inclusion criteria and were used to create a systematic evidence map. The Plastic Health Map with extracted metadata from included studies are freely available at https://osf.io/fhw7d/ and summary tables, plots and overall observations are included in this report.
CONCLUSIONS CONCLUSIONS
We present the first evidence map compiling human health research on a wide range of plastic-associated chemicals from several different chemical classes, in order to provide stakeholders, including researchers, regulators, and concerned individuals, with an efficient way to access published literature on the matter and determine knowledge gaps. We also provide examples of data clusters to facilitate systematic reviews and research gaps to help direct future research efforts. Extensive gaps are identified in the breadth of populations, exposures and outcomes addressed in studies of potential human health effects of plastic-associated chemicals. No studies of the human health effects of micro and/or nanoplastics were found, and no studies were found for 26/1,202 additives included in our search that are of known hazard concern and confirmed to be in active production. Few studies have addressed recent "substitution" chemicals for restricted additives such as organophosphate flame retardants, phthalate substitutes, and bisphenol analogues. We call for a paradigm shift in chemical regulation whereby new plastic chemicals are rigorously tested for safety before being introduced in consumer products, with ongoing post-introduction biomonitoring of their levels in humans and health effects throughout individuals' life span, including in old age and across generations.

Identifiants

pubmed: 37948868
pii: S0160-4120(23)00498-1
doi: 10.1016/j.envint.2023.108225
pii:
doi:

Substances chimiques

Flame Retardants 0
Microplastics 0
Plasticizers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108225

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Bhedita J Seewoo (BJ)

Plastics, Minderoo Foundation, 171-173 Mounts Bay Road 6000, Perth, WA, Australia; School of Biological Sciences, The University of Western Australia, 35 Stirling Highway, Crawley, WA 6009, Australia.

Louise M Goodes (LM)

Plastics, Minderoo Foundation, 171-173 Mounts Bay Road 6000, Perth, WA, Australia; School of Biological Sciences, The University of Western Australia, 35 Stirling Highway, Crawley, WA 6009, Australia.

Louise Mofflin (L)

Plastics, Minderoo Foundation, 171-173 Mounts Bay Road 6000, Perth, WA, Australia; School of Biological Sciences, The University of Western Australia, 35 Stirling Highway, Crawley, WA 6009, Australia.

Yannick R Mulders (YR)

Plastics, Minderoo Foundation, 171-173 Mounts Bay Road 6000, Perth, WA, Australia; School of Biological Sciences, The University of Western Australia, 35 Stirling Highway, Crawley, WA 6009, Australia.

Enoch Vs Wong (EV)

Plastics, Minderoo Foundation, 171-173 Mounts Bay Road 6000, Perth, WA, Australia; School of Biological Sciences, The University of Western Australia, 35 Stirling Highway, Crawley, WA 6009, Australia.

Priyanka Toshniwal (P)

Plastics, Minderoo Foundation, 171-173 Mounts Bay Road 6000, Perth, WA, Australia; School of Biological Sciences, The University of Western Australia, 35 Stirling Highway, Crawley, WA 6009, Australia.

Manuel Brunner (M)

Plastics, Minderoo Foundation, 171-173 Mounts Bay Road 6000, Perth, WA, Australia; School of Molecular Sciences, The University of Western Australia, 35 Stirling Highway, Crawley, WA 6009, Australia.

Jennifer Alex (J)

Plastics, Minderoo Foundation, 171-173 Mounts Bay Road 6000, Perth, WA, Australia.

Brady Johnston (B)

Plastics, Minderoo Foundation, 171-173 Mounts Bay Road 6000, Perth, WA, Australia.

Ahmed Elagali (A)

Plastics, Minderoo Foundation, 171-173 Mounts Bay Road 6000, Perth, WA, Australia; School of Biological Sciences, The University of Western Australia, 35 Stirling Highway, Crawley, WA 6009, Australia.

Aleksandra Gozt (A)

Plastics, Minderoo Foundation, 171-173 Mounts Bay Road 6000, Perth, WA, Australia.

Greg Lyle (G)

Plastics, Minderoo Foundation, 171-173 Mounts Bay Road 6000, Perth, WA, Australia; School of Population Health, Curtin University, Kent St, Bentley WA 6102, Australia.

Omrik Choudhury (O)

Plastics, Minderoo Foundation, 171-173 Mounts Bay Road 6000, Perth, WA, Australia.

Terena Solomons (T)

Plastics, Minderoo Foundation, 171-173 Mounts Bay Road 6000, Perth, WA, Australia; Health and Medical Sciences (Library), The University of Western Australia, 35 Stirling Highway, Crawley, WA 6009, Australia.

Christos Symeonides (C)

Plastics, Minderoo Foundation, 171-173 Mounts Bay Road 6000, Perth, WA, Australia; Murdoch Children's Research Institute, Royal Children's Hospital, 50 Flemington Rd, Parkville, VIC 3052, Australia.

Sarah A Dunlop (SA)

Plastics, Minderoo Foundation, 171-173 Mounts Bay Road 6000, Perth, WA, Australia; School of Biological Sciences, The University of Western Australia, 35 Stirling Highway, Crawley, WA 6009, Australia. Electronic address: plastichumanhealthreviews@minderoo.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH